Company: PTPI
Filing Date: 2025-09-05
Form Type: 8-K
Source: 0001104659-25-087887
Chunk: 1

Company: Petros Pharmaceuticals, Inc.
Filing Date: 2025-09-05
Form: 8-K
Item: Item 4.01
Chunk 1
---
the “ SEC”)
and requested that CBIZ CPAs furnish the Company with a letter addressed to the SEC, pursuant to Item 304(a)(3) of Regulation S-K, stating
whether it agrees with the above statements and, if it does not agree, the respects in which it does not agree. A copy of the letter,
dated September 5, 2025, is filed as Exhibit 16.1 (which is incorporated by reference herein) to this Current Report on Form 8-K.

(b) Appointment
of New Independent Registered Public Accounting Firm

On August 29, 2025, the Committee engaged HTL International, LLC (“ HTL”)
as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2025, effective immediately.
During the fiscal years ended December 31, 2024, and December 31, 2023, and the subsequent interim period through August 29, 2025, neither
the Company nor anyone on its behalf has consulted with HTL regarding (i) the application of accounting principles to any specified transaction,
either completed or proposed, or the type of audit opinion that might be rendered on the Company’s financial statements, and neither
a written report nor oral advice was provided to the Company that HTL concluded was an important factor considered by the Company in
reaching a decision as to any accounting, auditing, or financial reporting issue, or (ii) any matter that was either the subject of a
“disagreement,” as defined in Item 304(a)(1)(iv) of Regulation S-K, or a “reportable event,” as defined in Item
304(a)(1)(v) of Regulation S-K.